Trial Details
Not RecruitingBasic Information
| Clinical ID | c4990 |
|---|---|
| Identifier | ISRCTN45176516 |
| Trial Title | Impact of biologic and immunomodulatory therapy on SARS-CoV-2 infection and immunity in patients with inflammatory bowel disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | COVID-19 (SARS-CoV-2 infection), inflammatory bowel disease Infections and Infestations |
| Interventions | Workflow 1: Retrospective study of SARS-CoV-2 seroprevalence across the UK using surplus serum samples.Using the Roche Elecsys assay the researchers will test >7500 serum samples from IBD patients for SARS-CoV-2 antibodies. These include: i) surpl |
Participant Information
| Sponsor | Royal Devon & Exeter NHS Foundation Trust |
|---|---|
| City | NULL |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Observational |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |